Physician profile
David C Browning
NPI 1770899437
$7,720.91
in general payments reported to CMS, 2019-2025
14 companies · $4,818 in 2025
The $4,818 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $851 · 2020: $594 · 2022: $277 · 2023: $900 · 2024: $281 · 2025: $4,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,500 · Food and Beverage: $1,386 · Travel and Lodging: $1,092 · Entertainment: $20.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,500.00 |
| Food and Beverage | $1,386.28 |
| Travel and Lodging | $1,092.47 |
| Entertainment | $20.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $6,008.45 | 2019-2025 | Biofinity Contact Lens, Cvi Contact Lens, Myday Contact Lens |
| Glaukos Corporation | $336.77 | 2022-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished), Istent Inject Trabecular Micro-Bypass System |
| Alcon Vision LLC | $329.07 | 2019-2025 | Total30, Dailies Total1, Precision 7 |
| Bausch & Lomb Americas INC. | $209.49 | 2025 | Xiidra, Miebo, Infuse |
| Tarsus Pharmaceuticals, INC. | $144.55 | 2025 | Xdemvy |
| Abbvie INC. | $133.39 | 2022-2023 | Lumigan, Alphagan P, Vuity |
| Sun Pharmaceutical Industries INC. | $128.40 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Rxsight INC | $110.86 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Vision Care, INC. | $91.43 | 2019-2025 | Acuvue |
| Lkc Technologies, INC. | $44.85 | 2025 | |
| Allergan, INC. | $26.73 | 2022 | |
| Optos, INC. | $20.35 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.